0001615219-24-000015.txt : 20240222
0001615219-24-000015.hdr.sgml : 20240222
20240222163710
ACCESSION NUMBER: 0001615219-24-000015
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240222
DATE AS OF CHANGE: 20240222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rosenblum Mark J
CENTRAL INDEX KEY: 0001329154
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36812
FILM NUMBER: 24665483
MAIL ADDRESS:
STREET 1: 3990 SPRING VALLEY ROAD, APT. 1218
CITY: DALLAS
STATE: TX
ZIP: 75244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Salarius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001615219
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 465087339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
BUSINESS PHONE: 346-772-0346
MAIL ADDRESS:
STREET 1: 2450 HOLCOMBE BLVD
STREET 2: SUITE J-608
CITY: HOUSTON
STATE: TX
ZIP: 77021
FORMER COMPANY:
FORMER CONFORMED NAME: Flex Pharma, Inc.
DATE OF NAME CHANGE: 20140730
4
1
wk-form4_1708637819.xml
FORM 4
X0508
4
2024-02-20
0
0001615219
Salarius Pharmaceuticals, Inc.
SLRX
0001329154
Rosenblum Mark J
C/O SALARIUS PHARMACEUTICALS, INC.
2450 HOLCOMBE BLVD., SUITE X
HOUSTON
TX
77021
0
1
0
0
Exec VP Finance, CFO
0
Stock Option (right to buy)
0.5711
2024-02-20
4
A
0
22500
0
A
2025-02-20
2034-02-19
Common Stock
22500
22500
D
25% of the options are vested on February 20, 2025, and 1/36 of the remaining options vest on each monthly anniversary thereafter for 36 months.
/s/ Mark J. Rosenblum
2024-02-22